Bovine high-mountain disease (BHMD) is also known as brisket disease which causes significant death loss, especially in calves. The bovine high-mountain disease is right heart failure which is generally caused due to hypoxic pulmonary hypertension at high altitudes.
This report contains market size and forecasts of Bovine High Mountain Disease Drug in Global, including the following market information:
Global Bovine High Mountain Disease Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bovine High Mountain Disease Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diuretics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bovine High Mountain Disease Drug include Zoetis, Bayer, Eli Lilly, Dechra Pharmaceuticals and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bovine High Mountain Disease Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bovine High Mountain Disease Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bovine High Mountain Disease Drug Market Segment Percentages, by Type, 2021 (%)
Diuretics
Antibiotics
Appetite Stimulators
Others
Global Bovine High Mountain Disease Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bovine High Mountain Disease Drug Market Segment Percentages, by Application, 2021 (%)
Veterinary Hospitals
Veterinary Clinics
Others
Global Bovine High Mountain Disease Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bovine High Mountain Disease Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bovine High Mountain Disease Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bovine High Mountain Disease Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Zoetis
Bayer
Eli Lilly
Dechra Pharmaceuticals
Merck